Baidu
map
BIOCHEM PHARMACOL 润色咨询

BIOCHEMICAL PHARMACOLOGY

出版年份：1958 年文章数：5668 投稿命中率： 开通期刊会员，数据随心看

出版周期：Semimonthly 自引率：3.4% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管疾病<br>经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：3.8投稿，3.14 with editor，<br>一个多月后under review<br>后面四月底评审结束 <br>5.8 dip <br>5.12 reverse<br>5.20 resubmitted <br>5.28 with editor <br>6.3 under review <br>6.7评审结束 <br>6.11 二返（半月）<br>后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去 现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1083091, encodeId=8d64108309150, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：药理学;药理;毒理<br>经验分享：很速度的杂志，提交后1月左右返回修改意见，小修2周后返回，with editor后直接变成decision in process；最后4天后接受，不过杂志要求所有通讯都是机构邮箱，且不能有补充材料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Wed Dec 22 15:03:41 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2023-11-25 ms6000002140643083 来自安徽省

    送审后accept率高么

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管疾病<br>经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：3.8投稿，3.14 with editor，<br>一个多月后under review<br>后面四月底评审结束 <br>5.8 dip <br>5.12 reverse<br>5.20 resubmitted <br>5.28 with editor <br>6.3 under review <br>6.7评审结束 <br>6.11 二返（半月）<br>后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去 现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1083091, encodeId=8d64108309150, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：药理学;药理;毒理<br>经验分享：很速度的杂志，提交后1月左右返回修改意见，小修2周后返回，with editor后直接变成decision in process；最后4天后接受，不过杂志要求所有通讯都是机构邮箱，且不能有补充材料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Wed Dec 22 15:03:41 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2023-05-08 ms3000001240185836 来自四川省

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向：心血管疾病
    经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。

    30

    展开30条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管疾病<br>经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：3.8投稿，3.14 with editor，<br>一个多月后under review<br>后面四月底评审结束 <br>5.8 dip <br>5.12 reverse<br>5.20 resubmitted <br>5.28 with editor <br>6.3 under review <br>6.7评审结束 <br>6.11 二返（半月）<br>后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去 现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1083091, encodeId=8d64108309150, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：药理学;药理;毒理<br>经验分享：很速度的杂志，提交后1月左右返回修改意见，小修2周后返回，with editor后直接变成decision in process；最后4天后接受，不过杂志要求所有通讯都是机构邮箱，且不能有补充材料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Wed Dec 22 15:03:41 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2024-09-17 147a5c7fm07(暂无昵称) 来自吉林省

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管疾病<br>经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：3.8投稿，3.14 with editor，<br>一个多月后under review<br>后面四月底评审结束 <br>5.8 dip <br>5.12 reverse<br>5.20 resubmitted <br>5.28 with editor <br>6.3 under review <br>6.7评审结束 <br>6.11 二返（半月）<br>后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去 现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1083091, encodeId=8d64108309150, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：药理学;药理;毒理<br>经验分享：很速度的杂志，提交后1月左右返回修改意见，小修2周后返回，with editor后直接变成decision in process；最后4天后接受，不过杂志要求所有通讯都是机构邮箱，且不能有补充材料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Wed Dec 22 15:03:41 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2024-08-28 147a5c7fm07(暂无昵称) 来自吉林省

    8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管疾病<br>经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：3.8投稿，3.14 with editor，<br>一个多月后under review<br>后面四月底评审结束 <br>5.8 dip <br>5.12 reverse<br>5.20 resubmitted <br>5.28 with editor <br>6.3 under review <br>6.7评审结束 <br>6.11 二返（半月）<br>后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去 现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1083091, encodeId=8d64108309150, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：药理学;药理;毒理<br>经验分享：很速度的杂志，提交后1月左右返回修改意见，小修2周后返回，with editor后直接变成decision in process；最后4天后接受，不过杂志要求所有通讯都是机构邮箱，且不能有补充材料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Wed Dec 22 15:03:41 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2024-09-14 ms9000000714416538 来自北京

    通讯作者用的是163邮箱，会不会直接拒稿啊

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管疾病<br>经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：3.8投稿，3.14 with editor，<br>一个多月后under review<br>后面四月底评审结束 <br>5.8 dip <br>5.12 reverse<br>5.20 resubmitted <br>5.28 with editor <br>6.3 under review <br>6.7评审结束 <br>6.11 二返（半月）<br>后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去 现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1083091, encodeId=8d64108309150, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：药理学;药理;毒理<br>经验分享：很速度的杂志，提交后1月左右返回修改意见，小修2周后返回，with editor后直接变成decision in process；最后4天后接受，不过杂志要求所有通讯都是机构邮箱，且不能有补充材料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Wed Dec 22 15:03:41 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2024-04-12 ms6000002080703872 来自江苏省

    这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢

    5

    展开5条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管疾病<br>经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：3.8投稿，3.14 with editor，<br>一个多月后under review<br>后面四月底评审结束 <br>5.8 dip <br>5.12 reverse<br>5.20 resubmitted <br>5.28 with editor <br>6.3 under review <br>6.7评审结束 <br>6.11 二返（半月）<br>后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去 现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1083091, encodeId=8d64108309150, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：药理学;药理;毒理<br>经验分享：很速度的杂志，提交后1月左右返回修改意见，小修2周后返回，with editor后直接变成decision in process；最后4天后接受，不过杂志要求所有通讯都是机构邮箱，且不能有补充材料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Wed Dec 22 15:03:41 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2024-09-04 ms1000001788820000 来自上海

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向：医学
    经验分享：3.8投稿，3.14 with editor，
    一个多月后under review
    后面四月底评审结束
    5.8 dip
    5.12 reverse
    5.20 resubmitted
    5.28 with editor
    6.3 under review
    6.7评审结束
    6.11 二返（半月）
    后面又经历了催稿对接最后online。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管疾病<br>经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：3.8投稿，3.14 with editor，<br>一个多月后under review<br>后面四月底评审结束 <br>5.8 dip <br>5.12 reverse<br>5.20 resubmitted <br>5.28 with editor <br>6.3 under review <br>6.7评审结束 <br>6.11 二返（半月）<br>后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去 现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1083091, encodeId=8d64108309150, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：药理学;药理;毒理<br>经验分享：很速度的杂志，提交后1月左右返回修改意见，小修2周后返回，with editor后直接变成decision in process；最后4天后接受，不过杂志要求所有通讯都是机构邮箱，且不能有补充材料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Wed Dec 22 15:03:41 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2024-07-11 ms6000000678863567 来自湖北省

    2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去 现在还在等专家评审😭真的好久好久好久啊

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管疾病<br>经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：3.8投稿，3.14 with editor，<br>一个多月后under review<br>后面四月底评审结束 <br>5.8 dip <br>5.12 reverse<br>5.20 resubmitted <br>5.28 with editor <br>6.3 under review <br>6.7评审结束 <br>6.11 二返（半月）<br>后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去 现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1083091, encodeId=8d64108309150, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：药理学;药理;毒理<br>经验分享：很速度的杂志，提交后1月左右返回修改意见，小修2周后返回，with editor后直接变成decision in process；最后4天后接受，不过杂志要求所有通讯都是机构邮箱，且不能有补充材料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Wed Dec 22 15:03:41 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2024-06-02 ms1000000537292872 来自河北省

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，

    5

    展开5条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管疾病<br>经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224109, encodeId=4c28222410922, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：医学<br>经验分享：3.8投稿，3.14 with editor，<br>一个多月后under review<br>后面四月底评审结束 <br>5.8 dip <br>5.12 reverse<br>5.20 resubmitted <br>5.28 with editor <br>6.3 under review <br>6.7评审结束 <br>6.11 二返（半月）<br>后面又经历了催稿对接最后online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:18:38 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去 现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1083091, encodeId=8d64108309150, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：药理学;药理;毒理<br>经验分享：很速度的杂志，提交后1月左右返回修改意见，小修2周后返回，with editor后直接变成decision in process；最后4天后接受，不过杂志要求所有通讯都是机构邮箱，且不能有补充材料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Wed Dec 22 15:03:41 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2021-12-22 ms1000000096818640

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：药理学;药理;毒理
    经验分享：很速度的杂志，提交后1月左右返回修改意见，小修2周后返回，with editor后直接变成decision in process；最后4天后接受，不过杂志要求所有通讯都是机构邮箱，且不能有补充材料。

    1

    展开1条回复
共412条页码: 1/42页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map